, Tracking Stock Market Picks
Enter Symbol:
Antares Pharma, Inc. (ATRS) [hlAlert]

up 60.17 %

Antares Pharma, Inc. (AIS) rated Buy by Merriman

Posted on: Tuesday,  Nov 17, 2009  8:25 AM ET by Merriman

Merriman rated Buy Antares Pharma, Inc. (NASDAQ: ATRS) on 11/17/2009, when the stock price was $1.13. Since
then, Antares Pharma, Inc. has gained 60.18% as of 01/25/2016's recent price of $1.81.
If you would have followed this Merriman's recommendation on ATRS, you would have gained 60.17% of your investment in 2260 days.

Antares Pharma, Inc. (Antares) is a product development and pipeline company with drug delivery platforms, including Advanced Transdermal Delivery (ATD) gels, disposable pressure assisted auto injection systems (Vibex), reusable needle-free injection systems (VISION), disposable pen injection systems and oral disintegrating (Easy Tec) tablets. Two of these platforms have generated United States Food and Drug Administration (FDA) approved products. The Company develops, produces and markets pharmaceutical delivery products, including transdermal gels, oral disintegrating tablets and reusable needle-free and disposable pressure assisted auto injector and pen injector systems. The Company has operating facilities in the United States and Switzerland. Its United States operation manufactures and markets reusable needle-free injection devices and related disposables, and develops disposable pressure assisted auto injector and pen injector systems.

Merriman provides advanced tools for acquiring such information. These tools integrate a combination of cycles, geocosmic signatures and trend analysis patterns in assisting the serious investor in their interpretation of the various financial markets and the general economy. In today's fast paced and seemingly chaotic marketplace, you need the edge that only a broader analysis of human activity can provide.
Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
11/17/2009 8:25 AM Buy
as of 1/1/0001
1 Week   
1 Month   
3 Months   
1 YTD   

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy